Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Partners Investment

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 30
Average round size
The average size of a deal this fund participated in
Portfolio companies 26
Rounds per year 6.00
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 4

Areas of investment

  • Biotechnology
  • Software
  • Health Care
  • Gaming
  • Virtual Reality

The venture was found in Asia in South Korea. The main office of represented VC is situated in the Seoul.

Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Partners Investment performs on 21 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2018. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from Partners Investment is 10-50 millions dollars. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity.

Among the most successful fund investment fields, there are Business Development, Education. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Vedanta Biosciences, Bionetix, Moai Games For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 of the founder, the probability for it to get the investment is little.

Besides them, we counted 4 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Partners Investment, startups are often financed by Partners Venture Capital, Softbank Ventures Asia, Samsung Ventures. The meaningful sponsors for the fund in investment in the same round are Softbank Ventures Asia, Korea Investment Partners, Timewise Investment. In the next rounds fund is usually obtained by Samsung Ventures, Formation 8, Softbank Ventures Asia.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Partners Investment:
Typical Co-investors
Partners Investment is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Partners Investment:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arnoldo Mondadori Editore S.p.A Italy, Lombardy, Milan
Boulder Brands Boulder, Colorado, United States
Dianshi Equity Investment China, Shanxi, Yuci
Durable Capital Partners Chevy Chase, Maryland, United States
Magnum Technologies -
Nippon Electric Glass Japan, Otsu, Shiga Prefecture
Pinnacle Ventures California, Menlo Park, United States
Tianjin Boyi Chuangwei Touzi China, Guangdong, Tianjin
Vatera Healthcare Partners New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$32M08 Jun 2022 South Korea, Gangwon-do, South Korea


Media and Entertainment
Video on Demand
Video Streaming
Virtual Reality
$15M11 Jan 2022 California, United States


Web Development
$5M09 Dec 2021 San Francisco, California, United States


Health Care
Life Science
$30M18 Oct 2021 Singapore, Central Region, Singapore

Ring Therapeutics

Health Care
$117M28 Jul 2021 Cambridge, Massachusetts, United States

Senda Biosciences

Life Science
$98M10 Jun 2021 Cambridge, Massachusetts, United States


Digital Entertainment
$7M27 Apr 2021 Seongnam, Kyonggi-do, South Korea


$9M16 Apr 2021 South Korea, Gangwon-do, South Korea


Media and Entertainment
Video on Demand
Video Streaming
Virtual Reality
$9M08 Apr 2021 California, United States
Ring Therapeutics Raises $117M in Series B Funding

– Ring Therapeutics is a Cambridge, Mass.-based life sciences company.
– The company raised $117m in Series B funding.
– Backers included Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, alongside Flagship Pioneering.
– The new investment will be used for the continued development and expansion of its novel vector Anellogy™ platform.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Partners Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: